PLANT BIOLOGY
ANIMAL BIOLOGY
SUBSCRIPTION
E-SUBSCRIPTION
 
MAP
MAIN PAGE

 

 

 

 

Sukhinin A.A., Gumberidze M.M., Makavchik S.A., Nikonov B.A., Gusev V.I., Evsegneeva I.V., Becker G.P. Aleutian mink disease: the effectiveness of immunocorrective therapy. Sel'skokhozyaistvennaya Biologiya [Agricultural Biology], 2022, Vol. 57, № 2, p. 384-397.
(how to cite this article)

doi: 10.15389/agrobiology.2022.2.384reng

UDC: 636.934.57:619:616.9:578.822:

 

ALEUTIAN MINK DISEASE: THE EFFECTIVENESS OF IMMUNOCORRECTIVE THERAPY

A.A. Sukhinin1, M.M. Gumberidze1 ✉, S.A. Makavchik1,
B.A. Nikonov2, V.I. Gusev2, I.V. Evsegneeva2, G.P. Becker2

1Saint-Petersburg State University of Veterinary Medicine, 5, ul. Chernigovskaya, St. Petersburg, 196084 Russia, e-mail sukhininalexandr@mail.ru, maxim.gti@yandex.ru (✉ corresponding author), groza81@mail.ru;
2OOO «Alloferon» (Limited Liability Company), 14, ul. Shukhova, room 7, Moscow, 115162 Russia, e-mail skilledgoose@gmail.com

ORCID:
Sukhinin A.A. orcid.org/0000-0002-1245-3440
Evsegneeva I.V. orcid.org/0000-0001-5435-8938
Gumberidze M.M. orcid.org/0000-0003-0513-4430
Nikonov B.A. orcid.org/0000-0002-1388-6854
Makavchik S.A. orcid.org/0000-0001-5435-8321
Becker G.P. orcid.org/0000-0001-6302-450X
Gusev V.I. orcid.org/0000-0001-5551-1287

Received January 31, 2022

 

Aleutian mink disease is one of the main problems of fur farming, since it causes colossal losses to the industry due to the mass death of animals and due to the lack of effective means of treatment and prevention. In the presented work the results of using an antiviral agent based on alloferon Allokin-alpha in Aleutian mink disease are reported for the first time, an effective scheme of drug use has been developed, differences in clinical signs, blood biochemical parameters, morphological changes in internal organs have been established for animals with and without the peptide. The objective of our work was to evaluate the effectiveness of the use of the drug Allokin-alpha in Aleut mink disease and to investigate the effects of the drug as a means of immune correction, ensuring the maintenance of the body condition of sick minks. The experiments were performed in compliance with the requirements of the European Convention for the Protection of Vertebrate Animals used for experiments or for other scientific purposes. The research was conducted from May to December 2019 in one of the fur farms of the Northwestern region of the Russian Federation on the mink (Neovison vison Schreber, 1777) of the sapphire breed of 30-day age. The control and experimental groups included 5 males and 25 female mink each. All individuals in the experiment were intraperitoneally injected with Aleutian Mink disease virus (Sapphire isolate) at a dose of 2 cm3. The experimental minks were twice injected subcutaneously with the drug Allokin-alpha (0.5 mg per animal) with a 6-day interval. The control animals were injected subcutaneously with sterile saline solution (0.9 % NaCl) in the same dosage regimen. Clinical, laboratory and economic indicators were assessed in both groups over 6 months of the experiment. Minks’ mobility, coordination, appetite, color of the mucous membrane, fur condition and response to external stimuli were recorded. Animal mortality in both groups was checked daily, and all minks were weighed at the beginning of each month. Biochemical blood parameters were determined after 1, 3 and 6 months. Macroscopic, microscopic and chemical studies of feces were performed 3 days after repeated use of the drug Allokin alpha. At the end of the experiment, animals were subjected to diagnostic slaughter, the kidneys, spleen, ovaries of females and testes of males were collected. The biomaterial was fixed, dried, and poured into paraffin. Sections (5-7 microns thick) were stained with hematoxylin and eosin and examined under a microscope (LOMO Micromed-5, JSC LOMO, Russia). Our research data show that in the test group the minks were strong and had a proportional physique, the animals were very mobile and responded vividly to external stimuli compared to the control group, in which individuals exhibited reduced reactions, lethargy and drowsiness. The experimental minks had their digestion normalized. After receiving Allokin-alpha, the average bodyweight was 19.7 % higher in females and 15.6 % higher in males compared to control. The mortality in the test group was 0 % vs. 20 % in the control. The control animals had a high level of urea (84.05±4.22 mmol/l), creatinine (142.06±2.62 mmol/l), and transaminase activity (73.60±5.84 IU/l for ALT and 286.60±3.36 IU/l for AST). In contrast, in the experimental minks, the indicators were significantly lower, the 9.88±3.88 mmol/l for urea, 97.71±1.47 mmol/l for creatinine, 130.73±4.43 IU/l for ALT and 184.88±3.22 IU/l for AST. The use of Allokin-alpha caused a decrease in pH from 8.7±0.25 to 6.8±0.18 in feces. Intestinal epithelial cells, blood pigments, and soluble protein were not found in the feces of the experimental minks, but they appeared in the control minks, which indicated the normalization of digestion. Internal organs’ morphology showed the signs of glomerulonephritis and foci of lymphoplasmacytic infiltration of kidneys, spleen, liver and ovaries of female and testes of males. Nevertheless, these changes was much less pronounced in the test group than in the control group. Our findings indicate that the use of Allokin-alpha according to the developed scheme has a positive effect on the Aleutian mink disease symptoms, leads to a decrease in animals death, an increase in bodyweight gain and significantly reduces economic in losses.

Keywords: Aleutian mink disease, viral plasmocytosis, Allokin-alpha, alloferon, immunocorrector.

 

REFERENCES

  1. Tong M., Sun N., Cao Z., Cheng Y., Zhang M., Cheng S., Yi L. Molecular epidemiology of Aleutian mink disease virus from fecal swab of mink in northeast China. BMC Microbiol., 2020, 20: 234 CrossRef
  2. Prieto A., Fernández-Antonio R., López-Lorenzo G., Díaz-Cao J.M., López-Novo C., Remesar S., Panadero R., Díaz P., Morrondo P., Díez-Baños P., Fernández G. Molecular epidemiology of Aleutian mink disease virus causing outbreaks in mink farms from Southwestern Europe: a retrospective study from 2012 to 2019. J. Vet. Sci., 2020, 21(4): e65 CrossRef
  3. Slugin B.C. Krolikovodstvo i zverovodstvo, 2005, 1: 24-28 (in Russ.).
  4. Persson S., Jensen T.H., Blomström A.L., Appelberg M.T., Magnusson U. Aleutian mink disease virus in free-ranging mink from Sweden. PLoS One, 2015, 10(3): 0122194 CrossRef
  5. Farid A.H. Aleutian mink disease virus in furbearing mammals in Nova Scotia, Canada. Acta Vet. Scand., 2013, 55: 10 CrossRef
  6. Bessarabov B.F., Vashutin A.A., Voronin E.S. Infektsionnye bolezni zhivotnykh /Pod redaktsiei A.A. Sidorchuk [Infectious animal diseases. A.A. Sidorchuk (ed.)]. Moscow, 2007 (in Russ.).
  7. Mikheev Yu.V. Sovershenstvovanie laboratornoi diagnostiki aleutskoi bolezni norok. Avtoreferat kandidatskoi dissertatsii [Improvement of laboratory diagnostics of Aleutian mink disease. PhD Thesis]. Moscow, 2003 (in Russ.).
  8. Geller V.I., Semikrasova A.N., Petrova I.V. Krolikovodstvo i zverovodstvo, 2015, 6: 27-28 (in Russ.).
  9. Knuuttila A., Uzcátegui N., Kankkonen J., Vapalahti O., Kinnunen P. Molecular epidemiology of Aleutian mink disease virus in Finland. Veterinary Microbiology, 2009, 133 (3): 229-238 CrossRef
  10. Farid A.H., Smith N.J. Dietary supplementation of Ascophylum nodosum improved kidney function of mink challenged with Aleutian mink disease virus. BMC Vet. Res., 2020, 16: 465 CrossRef
  11. Karimi K., Farid A.H., Myles S., Miar Y. Detection of selection signatures for response to Aleutian mink disease virus infection in American mink. Sci. Rep., 2021, 11: 2944 CrossRef
  12. Kashtanov S.N., Salnikova L.E. Aleutian mink disease: epidemiological and genetic aspects. Biol. Bull. Rev., 2018, 8(2): 104-113 CrossRef
  13. Reichert M., Kostro K. Effect of persistent infection of mink with Aleutian mink disease virus on reproductive failure. Journal of Veterinary Research, 2014, 58(3): 369-373 CrossRef
  14. Castelruiz Y., Blixenkrone-Møller M., Aasted B. DNA vaccination with the Aleutian mink disease virus ND1 gene confer partial protection against disease. Vaccine, 2005, 23 (10): 1225-1231 CrossRef
  15. Liu D., Li J., Shi K., Zeng F., Zong Y., Leng X., Lu H., Du R. Construction and immunogenicity analysis of whole-gene mutation DNA vaccine of Aleutian mink virus isolated virulent strain. Viral Immunology, 2017, 31(1): 69-77 CrossRef
  16. Cotmore S.F., Agbandje-McKenna M., Chiorini J.A., Mukha D.V., Pintel D.J., Qiu J., Soderlund-Venermo M., Tattersall P., Tijssen P., Gatherer D., Davison A.J. The family Parvoviridae. Arch. Virol., 2014, 159(5): 1239-1247 CrossRef
  17. Farid A.H., Ferns L.E. Reduced severity of histopathological lesions in mink selected for tolerance to Aleutian mink disease virus infection. Research in Veterinary Science,2017, 111: 127-134 CrossRef
  18. Zalewski A., Virtanen J., Brzeziński M., Kołodziej-Sobocińska M., Jankow W., Sironen T. Aleutian mink disease: spatio-temporal variation of prevalence and influence on the feral American mink. Transboundary and Emerging Diseases,68(4): 2556-2570 CrossRef
  19. Hussain I., Price G.W., Farid A.H. Inactivation of Aleutian mink disease virus through high temperature exposure in vitro and under field-based composting conditions. Veterinary Microbiology,2014, 173(1-2): 50-58 CrossRef
  20. Jensen T.H., Chriél M., Hansen M.S. Progression of experimental chronic Aleutian mink disease virus infection. Acta Vet. Scand., 2016, 58: 35 CrossRef
  21. Huang Q., Luo Y., Cheng F., Best S.M., Bloom M.E., Qiu J. Molecular characterization of the small nonstructural proteins of parvovirus Aleutian mink disease virus (AMDV) during infection. Virology,2014, 452-453: 23-31 CrossRef
  22. Rakityanskaya I.A., Ryabova T.S., Todzhibaev U.A., Kalashnikova A.A. Voprosy virusologii,2019, 64(3): 118-124 CrossRef (in Russ.).
  23. Chernysh S., Kim S.I., Bekker G., Pleskach V.A., Filatova N.A., Anikin V.B., Platonov V.G., Bulet P. Antiviral and antitumor peptides from insects. Proceedings of the National Academy of Sciences,2002, 99(20): 12628-12632 CrossRef
  24. Menshenina A.P., Kit O.I., Moiseenko T.I., Frantsiyants E.M., Zlatnik E.Y., Verenikina E.V., Ushakova N.D., Goroshinskaya I.G., Shikhlyarova A.I. Combination treatment with plasmapheresis and non-specific immunotherapy for locally advanced cervical cancer. Journal of Critical Reviews,2020, 7(12): 2235-2241.
  25. Chernysh S.I., Gordja N.A. The immune system of maggots of the blow fly (Calliphora vicina) as a source of medicinal drugs. J. Evol. Biochem. Phys.,2011, 47: 524-533 CrossRef
  26. Kutsenko I.I., Borovikov I.O., Dekhtyarenko Yu.V., Bulgakova V.P. Vestnik Rossiiskogo universiteta druzhby narodov. Seriya: Meditsina,2012, 5: 334-341 (in Russ.).
  27. Konovalova N.V., Khramenko N.I., Velichko L.N., Yurchenko L.A. Tochka zreniya. Vostok — Zapad,2018, 4: 26-29 CrossRef (in Russ.).
  28. Alspach E., Lussier D.M., Schreiber R.D. Interferon γ and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity. Cold Spring Harbor Perspectives in Biology, 2019, 11(3): a028480 CrossRef
  29. Burke S.J., Updegraff B.L., Bellich R.M., Goff M.R., Lu D., Minkin S.C. Jr., Karlstad M.D., Collier J.J. Regulation of iNOS gene transcription by IL-1β and IFN-γ requires a coactivator exchange mechanism. Molecular Endocrinology, 2013, 27(10): 1krut724-1742 CrossRef
  30. Petrov R.V., Ataullakhanov R.I. Kletochnye membrany i immunitet. Biokhimiya membran. Kniga 9 /Pod redaktsiei A.A. Boldyreva [Cell membranes and immunity. Biochemistry of cell membranes. Book 9 /A.A. Boldyrev (ed.)]. Moscow, 1991 (in Russ.).
  31. Konovalova N.V., Khramenko N.I., Velichko L.N. Tochka zreniya. Vostok — Zapad,2017, 3: 57-60 (in Russ.).
  32. Tyn'o Ya.Ya., Yarygina E.I., Ustinova V.A., Vidrashko M.T., Morozova G.V., Bakaeva E.V. Rossiiskaya sel'skokhozyaistvennaya nauka, 2017, 6: 48-51 (in Russ.).
  33. Evropeiskaya konventsiya o zashchite pozvonochnykh zhivotnykh, ispol'zuemykh dlya eksperimentov ili v inykh nauchnykh tselyakh (ETS № 123) (Strasburg 18.03.1986). Available: http://www.conventions.ru/view_base.php?id=19432 [European convention for the protection of vertebrate animals used for experimental or other scientific purposes (ETS No. 123) (Strasbourg 03.18.1986)]. No date (in Russ.).
  34. Sukhinin A.A. Laboratornaya diagnostika virusnykh boleznei [Laboratory diagnosis of viral diseases]. St. Petersburg, 2019 (in Russ.).
  35. Pis'mennaya S.V. Issledovanie soderzhimogo kishechnika [Examination of the contents of the intestine]. Arkhangel'sk, 2013 (in Russ.)
  36. Rostrosa P., Sanin A., Narovlyanskiy A., Pronin A., Kozhevnikova T. Increasing the natural resistance and survival of minks in case of unfavorable course of Aleutian disease. Russian Veterinary Journal, 2019, (6): 14-19 CrossRef
  37. Bespyatykh O.Yu., Berezina Yu.A., Bel'tyukova Z.N., Okulova I.I., Domskii I.A., Zhuravlev D.M. Veterinarnaya patologiya,2011, 3(37): 75-78 (in Russ.).
  38. Batoev Ts.Zh., Sanzhieva S.E., Berdnikov P.P., Mantatova N.V. VestnikBuryatskogo gosudarstvennogo universiteta. Biologiya, geografiya,2013, 4: 179-184 (in Russ.).
  39. Mantatova N.V., Kladova D.V. Vestnik Altaiskogo gosudarstvennogo agrarnogo universiteta,2019, 11(181): 133-138 (in Russ.).

 

back

 


CONTENTS

 

 

Full article PDF (Rus)

Full article PDF (Eng)